EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Favorable Effects of Renal Denervation in Hypertension‐Related Comorbidities. A Systematic Review and Meta‐Analysis

Athanasios Makris iD, Stergios Soulaidopoulos, Marios Sagris iD, Konstantinos Platanias iD, Konstantinos Kyriakoulis, Dimitrios Konstantinidis, Fotis Tatakis, Georgios Gompos, Kyriakos Dimitriadis iD, Athanasios Kordalis iD, Dimitrios Tsiachris, Nikos Kafkas und 2 weitere

Catheterization and Cardiovascular Interventions · 2026-06 · 107 (7) · 2153-2161

DOI: 10.1002/ccd.70600 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Catheterization and Cardiovascular Interventions, online erschienen am 02.04.2026. Verfasst von Athanasios Makris und 13 weiteren Autor:innen. Beteiligte Einrichtung: 1st Cardiology Department, Hippokrateion General Hospital, Thessaloniki, Greece. Hauptthemen laut MEDLINE: Hypertension, Sympathectomy, Kidney, Blood Pressure. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Renal denervation (RDN) according to the latest ESH guidelines can be considered as a treatment option for patients with resistant hypertension. However, excess sympathetic nervous system activity constitutes an underlying pathophysiological mechanism in many disorders other than arterial hypertension.

Aims

This systematic review and meta‐analysis investigated the therapeutic effects of RDN beyond arterial hypertension.

Methods

A systematic review and meta‐analysis were conducted following PRISMA guidelines. Electronic databases (PubMed, Embase, Cochrane) were searched for studies assessing RDN effects in atrial fibrillation (AF) recurrence, obstructive sleep apnea (OSA), metabolic parameters, heart failure (HF) and diastolic heart function. Inclusion criteria encompassed randomized controlled trials and observational studies with relevant outcome measures. Effect sizes were pooled using a random‐effects model.

Results

A total of 16 studies comprising 818 patients were included. RDN was associated with a significant increase in freedom from AF when combined with pulmonary vein isolation (RR: 1.30, 95% CI: 1.04 to 1.61, I 2 = 5%), an improvement in OSA severity as measured by the apnea‐hypopnea index (MD: −4.80, 95% CI: −12.60 to 3.01, I 2 = 39%), and decreased fasting blood glucose (MD: −10.04, 95% CI: −26.51 to 6.43, I 2 = 0%). Additionally, RDN led to improvements in left ventricular diastolic function in terms of E/e' reduction (MD: −1.51, 95% CI: −2.71 to −0.31, I 2 = 94%) and improved HF‐related biomarkers, specifically NT pro‐BNP (MD: −438.54, 95% CI: −1658.57 to 781.49, I 2 = 92%) and 6‐min walking distance (MD: +64.58, 95% CI: 0.11 to 129.05, I 2 = 53%).

Conclusion

This meta‐analysis suggests that RDN exerts beneficial effects beyond hypertension, particularly in AF burden, OSA severity, metabolic parameters, and cardiac function. These findings support the broader role of RDN in autonomic regulation and cardiovascular health. Further large‐scale trials are warranted to confirm these effects and refine patient selection criteria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypertensionSympathectomyKidneyBlood PressureSleep Apnea, ObstructiveSympathetic Nervous SystemAtrial FibrillationRenal ArteryHumansTreatment OutcomeFemaleMaleComorbidityMiddle AgedAgedRisk FactorsRecovery of FunctionHeart Failure

Stichwörter der Autor:innen

atrial fibrillationautonomic nervous systemdiastolic functionheart failureinsulin resistanceobstructive sleep apnearenal denervation

Autor:innen und Institutionen

  • 1st Cardiology Department, Hippokrateion General Hospital, Thessaloniki, Greece.
  • Cardiology Department, Hospital KAT, Athens, Greece.
  • Berlin Institute of Health (BIH) at Charité, Berlin, Germany.

ORCID-Profile: Athanasios Makris, Marios Sagris, Konstantinos Platanias, Kyriakos Dimitriadis, Athanasios Kordalis

Zitieren

APA

Makris, A., Soulaidopoulos, S., Sagris, M., Platanias, K., Kyriakoulis, K., Konstantinidis, D., Tatakis, F., Gompos, G., Dimitriadis, K., Kordalis, A., Tsiachris, D., Kafkas, N., Waliszewski, M., & Tsioufis, K. (2026). Favorable Effects of Renal Denervation in Hypertension‐Related Comorbidities. A Systematic Review and Meta‐Analysis. Catheterization and Cardiovascular Interventions, 107(7), 2153-2161. https://doi.org/10.1002/ccd.70600

Vancouver

Makris A, Soulaidopoulos S, Sagris M, Platanias K, Kyriakoulis K, Konstantinidis D, et al. Favorable Effects of Renal Denervation in Hypertension‐Related Comorbidities. A Systematic Review and Meta‐Analysis. Catheterization and Cardiovascular Interventions. 2026;107(7):2153-2161. doi:10.1002/ccd.70600

BibTeX
@article{Makris2026,
  author = {Makris, Athanasios and Soulaidopoulos, Stergios and Sagris, Marios and Platanias, Konstantinos and Kyriakoulis, Konstantinos and Konstantinidis, Dimitrios and Tatakis, Fotis and Gompos, Georgios and Dimitriadis, Kyriakos and Kordalis, Athanasios and Tsiachris, Dimitrios and Kafkas, Nikos and Waliszewski, Matthias and Tsioufis, Konstantinos},
  title = {Favorable Effects of Renal Denervation in Hypertension‐Related Comorbidities. A Systematic Review and Meta‐Analysis},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2026},
  volume = {107},
  number = {7},
  pages = {2153--2161},
  doi = {10.1002/ccd.70600}
}
Kostenlos starten →